The effect of finasteride and hydroxy chloroquine on frontal fibrosing alopecia
Phase 2
Recruiting
- Conditions
- Frontal fibrosing alopecia.Cicatricial alopecia, unspecifiedL66.9
- Registration Number
- IRCT20210513051276N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
New cases with FFA who have not yet received any medication.
Patients who have previously received systemic therapy and have not received systemic medication for at least the last three months and according to clinical and dermoscopic criteria, their disease is active.
Patients treated with topical medication and according to clinical and dermoscopic criteria, their disease is active
Exclusion Criteria
Pregnancy or lactation
History of hypersensivity due to hydroxychloroquine or finasteride
Patients with severe blood dyscrasia and liver dysfunction
Patients with retinopathy
Personal history or family history of breast cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frontal fibrosing alopecia severity index. Timepoint: Before and after intervention. Method of measurement: Checklist.;Standardized global photography. Timepoint: Before and after intervention. Method of measurement: Based on scoring by two dermatologist.;Tricoscopy. Timepoint: Before and after intervention. Method of measurement: Based on scoring by two dermatologist.
- Secondary Outcome Measures
Name Time Method